Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about psilocybin therapy
Recent news which mentions psilocybin therapy
Kaya Holdings Advocates For Psilocybin As FDA Rejects MDMA For PTSD Treatment
August 14, 2024
Tickers
KAYS
NEWS
Tags
News
Craig Frank
Regulations
From
Benzinga
Utah Hospitals Will Soon Provide Psilocybin And MDMA Therapy For Mental Health Conditions
March 25, 2024
Tickers
NEWS
NUMIF
Tags
News
NUMIF
Cannabis
From
Benzinga
Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More
March 04, 2024
Tickers
ATAI
CMND
CMPS
CYBN
Tags
Psychedelics
SPRC
IXHL
From
Benzinga
Washington Doctor Vs. DEA For Lawful Use Of Psilocybin To Treat Terminally Ill Patients
February 14, 2024
Tickers
NEWS
Tags
News
right/to/try laws
Psychedelics
From
Benzinga
Canadian At-Home Microdose Psilocybin Clinical Trial Finalized, Here Are The Details
March 31, 2023
Tags
News
Psilocybin Microdosing
Benzinga
From
Benzinga
Meth Use Disorder Tackled With Psilocybin: Clinical Trial Begins Patient Enrollment
March 28, 2023
Tickers
RVVTF
Tags
Market News
psilocybin therapy
Cannabis
From
Benzinga
Canada's Ongoing Struggle For Access To Natural Psilocybin As A Therapeutic Nabs Business Support
February 15, 2023
Tickers
TRUFF
Tags
Markets
TheraPsil
Market News
From
Benzinga
Canadian Psychedelics Company Launches Take-Home Psilocybin Trial For Some 300 Participants
February 01, 2023
Tags
News
Markets
Market News
From
Benzinga
Virginia Psychedelics: Legalizing Medical Use Of Psilocybin Gets A Thumbs Down
January 20, 2023
Tags
Markets
Market News
psilocybin therapy
From
Benzinga
2023 Could Be Make Or Break For Psychedelics In Missouri, This GOP Lawmaker Is Pushing For Change
January 09, 2023
Tags
News
Psychedelics
Benzinga
From
Benzinga
What Happened With Psychedelics In The Last Year? 11 Key News Items, The Sector's Performance & Takeaways
January 03, 2023
Tickers
ATAI
AWKNF
CMND
CMPS
Tags
Psychedelics
Psychedelic/Assisted Therapies
Health Canada
From
Benzinga
Oregon's Final Rules For Psilocybin Services Are Ready, Learn What To Expect
December 28, 2022
Tags
Government
Regulations
Benzinga
From
Benzinga
First-Ever Clinical Trial On Magic Mushroom Therapy For Autism's Genetic Cause Receives Approval
December 27, 2022
Tickers
KONEF
NMLSF
Tags
Fragile X Syndrome
Markets
Cannabis
From
Benzinga
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries
December 21, 2022
Tags
News
Benzinga
Psychedelics
From
Benzinga
Potential Road To At-Home Psychedelics Use Permits: Low Dosing's Positive Outcomes In Phase 1 Trial
December 12, 2022
Tags
Non/Hallucinogenic Psychedelics
Markets
Market News
From
Benzinga
Magic Mushrooms Tested For Treating Type II Bipolar Disorder, Check Out Results So Far
December 12, 2022
Tickers
CMPS
Tags
psilocybin therapy
Small Cap
CMPS
From
Benzinga
DEA's Consistent Denial Of Psilocybin Access For Terminally Ill Being Challenged Again
October 27, 2022
Tickers
CSA
DEA
Tags
CSA
DEA
Markets
From
Benzinga
In Oregon You Can Get Trained To Be A Licensed Psilocybin Therapy Provider
October 07, 2022
Tags
Markets
psilocybin therapy
Cannabis
From
Benzinga
Cannabis & Psychedelics As Effective Adjunct Medicine To Breast Cancer Therapy? Studies Say Yes
September 30, 2022
Tags
General
psilocybin therapy
Nicole Di Monda
From
Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: What Science Is Saying
September 22, 2022
Tickers
CMPS
Tags
Psychedelics
Benzinga
Anorexia Nervosa
From
Benzinga
Why Magic Mushrooms Are Emerging As Major Part Of Public Discourse: The Legal Situation
September 19, 2022
Tags
Market News
psilocybin therapy
Cannabis
From
Benzinga
Major Psychedelics Firm Is Studying Magic Mushrooms To Treat Meth Addiction
September 16, 2022
Tickers
RVVTF
Tags
Cannabis
Market News
Markets
From
Benzinga
Mindset Pharma Meets With UK Regulator: Is A Phase 1 Trial Getting Close?
September 14, 2022
Tickers
MSSTF
Tags
Market News
Cannabis
James Lanthier
From
Benzinga
Psychedelics Companies Are Teaming Up To Offer Access Veterans
September 13, 2022
Tickers
AWKNF
RVLWF
Tags
Management
psilocybin therapy
RVLWF
From
Benzinga
Cathie Wood's Psychedelics Fund ARK Analyzes The Sector's Present & Future And Likes What It Sees
September 06, 2022
Tickers
ATAI
Tags
Psychedelics
Benzinga
Small Cap
From
Benzinga
Study Finds Psilocybin Anti-Depression Effects Last At Least One Year
March 04, 2022
Tags
psychedelics
Benzinga
contributors
From
Benzinga
The Case For Psilocybin Therapy And Depression
January 30, 2022
Tags
Benzinga
contributors
depression
From
Benzinga
ATAI Life Sciences Announces New Program To Discover Next-Generation Mental Health Treatments
January 27, 2022
Tickers
ATAI
Tags
PTSD
psilocybin therapy
General
From
Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants Is Possible, COMPASS Study Confirms
December 13, 2021
Tickers
CMPS
Tags
Benzinga
Psilocybin Therapy Combined With SSRI Antidepressants
Guy Goodwin
From
Benzinga
Peter Thiel-Backed Psychedelic Start-Up, ATAI Life Sciences, Increases Stake In Compass Pathways
November 29, 2021
Tickers
ATAI
CMPS
Tags
Markets
Compass Pathways
Market News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.